已收录 268921 条政策
 政策提纲
  • 暂无提纲
Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
[摘要] References(15)Cited-By(6)To assess the pharmacological profile of AS1892802, a novel and selective Rho kinase (ROCK) inhibitor, we examined the effects of repeated dosing with AS1892802 on models of monoiodoacetate-induced arthritis and streptozotocin-induced neuropathy. Although single dosing of AS1892802 exerted a short-acting, moderate analgesic effect, repeated dosing exhibited a long-lasting and more potent analgesic effect in both models. Furthermore, the analgesic effect was sustained for seven days after the last administration. These results suggest that peripheral ROCK plays a crucial role in chronic pain maintenance and that AS1892802 may be useful in treating chronic pain.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药学
[关键词] Rho kinase;monoiodoacetate-induced arthritis;streptozotocin-induced neuropathy [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文